These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 31153713)

  • 41. Antimicrobial resistance of bacteraemia in the emergency department of a German university hospital (2013-2018): potential carbapenem-sparing empiric treatment options in light of the new EUCAST recommendations.
    Rothe K; Wantia N; Spinner CD; Schneider J; Lahmer T; Waschulzik B; Schmid RM; Busch DH; Katchanov J
    BMC Infect Dis; 2019 Dec; 19(1):1091. PubMed ID: 31888581
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Impact of the Antimicrobial Stewardship Team Intervention Focusing on Changes in Prescribing Trends and the Rate of Carbapenem-resistant P. aeruginosa].
    Naito Y; Maeda M; Nagatomo Y; Ugajin K; Akima E; Tanaka M; Tokimatsu I; Sasaki T
    Yakugaku Zasshi; 2022; 142(5):527-534. PubMed ID: 35491159
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk Factors for Carbapenem-Resistant Pseudomonas aeruginosa, Zhejiang Province, China.
    Hu YY; Cao JM; Yang Q; Chen S; Lv HY; Zhou HW; Wu Z; Zhang R
    Emerg Infect Dis; 2019 Oct; 25(10):1861-1867. PubMed ID: 31538558
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sustained pediatric antimicrobial stewardship program with consultation to infectious diseases reduced carbapenem resistance and infection-related mortality.
    Horikoshi Y; Suwa J; Higuchi H; Kaneko T; Furuichi M; Aizawa Y; Fukuoka K; Okazaki K; Ito K; Shoji T
    Int J Infect Dis; 2017 Nov; 64():69-73. PubMed ID: 28941633
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibiotic consumption versus the prevalence of carbapenem-resistant Gram-negative bacteria at a tertiary hospital in China from 2011 to 2017.
    Zhang D; Hu S; Sun J; Zhang L; Dong H; Feng W; Lei J; Dong Y
    J Infect Public Health; 2019; 12(2):195-199. PubMed ID: 30385238
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Trends and relationship between antimicrobial resistance and antibiotic use in Xinjiang Uyghur Autonomous Region, China: Based on a 3 year surveillance data, 2014-2016.
    Wushouer H; Zhang ZX; Wang JH; Ji P; Zhu QF; Aishan R; Shi LW
    J Infect Public Health; 2018; 11(3):339-346. PubMed ID: 29017750
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cumulative Effect of an Antimicrobial Stewardship and Rapid Diagnostic Testing Bundle on Early Streamlining of Antimicrobial Therapy in Gram-Negative Bloodstream Infections.
    Bookstaver PB; Nimmich EB; Smith TJ; Justo JA; Kohn J; Hammer KL; Troficanto C; Albrecht HA; Al-Hasan MN
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630187
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of an infectious diseases specialist-led antimicrobial stewardship programmes on antibiotic use and antimicrobial resistance in a large Korean hospital.
    Hwang H; Kim B
    Sci Rep; 2018 Oct; 8(1):14757. PubMed ID: 30283084
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Trend analysis of antimicrobial consumption and development of resistance in non-fermenters in a tertiary care hospital in Delhi, India.
    Goel N; Wattal C; Oberoi JK; Raveendran R; Datta S; Prasad KJ
    J Antimicrob Chemother; 2011 Jul; 66(7):1625-30. PubMed ID: 21586594
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Feasibility of Core Antimicrobial Stewardship Interventions in Community Hospitals.
    Anderson DJ; Watson S; Moehring RW; Komarow L; Finnemeyer M; Arias RM; Huvane J; Bova Hill C; Deckard N; Sexton DJ;
    JAMA Netw Open; 2019 Aug; 2(8):e199369. PubMed ID: 31418804
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Systematic Review and Meta-analysis of Clinical and Economic Outcomes from the Implementation of Hospital-Based Antimicrobial Stewardship Programs.
    Karanika S; Paudel S; Grigoras C; Kalbasi A; Mylonakis E
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4840-52. PubMed ID: 27246783
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Trends in Antipseudomonal Agent Use Based on the 2006 to 2015 Sales Data in Japan.
    Ebisui A; Inose R; Kusama Y; Koizumi R; Kawabe A; Ishii S; Goto R; Ishikane M; Yagi T; Ohmagari N; Muraki Y
    Biol Pharm Bull; 2021; 44(6):816-821. PubMed ID: 34078813
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk factors for hospitalized patients with resistant or multidrug-resistant
    Raman G; Avendano EE; Chan J; Merchant S; Puzniak L
    Antimicrob Resist Infect Control; 2018; 7():79. PubMed ID: 29997889
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of regular reporting on local Pseudomonas aeruginosa and Acinetobacter spp. sensitivity to antibiotics on consumption of antibiotics and resistance patterns.
    Djordjevic ZM; Folic MM; Jankovic SM
    J Clin Pharm Ther; 2017 Oct; 42(5):585-590. PubMed ID: 28556289
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hand hygiene, and not ertapenem use, contributed to reduction of carbapenem-resistant Pseudomonas aeruginosa rates.
    Pires dos Santos R; Jacoby T; Pires Machado D; Lisboa T; Gastal SL; Nagel FM; Kuplich NM; Konkewicz L; Gorniak Lovatto C; Pires MR; Goldani LZ
    Infect Control Hosp Epidemiol; 2011 Jun; 32(6):584-90. PubMed ID: 21558771
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Does ertepenem alter the susceptibility of Pseudomonas aeruginosa to carbapenems?
    Beović B; Kreft S; Seme K; Cizman M
    J Chemother; 2011 Aug; 23(4):216-20. PubMed ID: 21803699
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Carbapenem-Resistant Pseudomonas aeruginosa Bacteremia: Risk Factors for Mortality and Microbiologic Treatment Failure.
    Buehrle DJ; Shields RK; Clarke LG; Potoski BA; Clancy CJ; Nguyen MH
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27821456
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of antimicrobial consumption on gram-negative bacteria in inpatients receiving antimicrobial resistance therapy from 2008-2013 at a tertiary hospital in Shanghai, China.
    Guo W; He Q; Wang Z; Wei M; Yang Z; Du Y; Wu C; He J
    Am J Infect Control; 2015 Apr; 43(4):358-64. PubMed ID: 25838134
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical review: balancing the therapeutic, safety, and economic issues underlying effective antipseudomonal carbapenem use.
    Slama TG
    Crit Care; 2008; 12(5):233. PubMed ID: 18983709
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of carbapenem-resistant Pseudomonas aeruginosa in selected hospitals of the Gulf Cooperation Council States: dominance of high-risk clones in the region.
    Zowawi HM; Syrmis MW; Kidd TJ; Balkhy HH; Walsh TR; Al Johani SM; Al Jindan RY; Alfaresi M; Ibrahim E; Al-Jardani A; Al Salman J; Dashti AA; Sidjabat HE; Baz O; Trembizki E; Whiley DM; Paterson DL
    J Med Microbiol; 2018 Jun; 67(6):846-853. PubMed ID: 29664716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.